Methods: Cynomolgus monkeys were divided as follows: Control, 6-12 months (M1), 3-4 (M2) and 7-9 (M3) years, and more than 11 years (M4). After the administration of METH in cynomolgus monkeys on an age-dependent dose (2 mg/kg, intramuscular injection in M1, M2, M3 and M4), transcriptome profiling in the hippocampus was performed using RNA-seq technology. The functions and networks of analyzed DEGs were classified using GO analysis tool (DAVID) and IPA software. Results: In METH-treated animals, the correlation of DEGs between M1 and M4 was higher than other groups, showing the possibility that biological mechanisms in the hippocampus of M1 and M4 are similarly affected by METH. Based on the GO analysis using the DEGs, transmission of nerve impulse (GO:0019226) and synaptic transmission (GO:0007268) were significantly ranked within top three of GO biological process (BP) terms in all age monkeys exposed to METH compared to the control. On the other hand, neuron development (GO:0048666) was ranked within top five of GO BP terms in M1, M2 and M3 monkeys except for M4. Peroxiredoxin 3 was highly upregulated in METH-treated groups, while HSPB6 was downregulated compared to the control. Conclusions: Our results suggest not only molecular mechanisms related to the DEGs in the impaired hippocampus but also a clue for developing METH addiction marker according to ages. 
p<0.001). Within the records of falls (W00-W19), 8.02% of subjects diagnosed with Mental and behavioral disorders and/or diseases of the nervous system were found, whereas those with other ICD-10 categories also resulted with the less rigid of 2.9% (OR = 2.92, 95%CI = 2.87-2.97, p<0.001). The determination of associated factors would be in the further analysis.
Conclusion:
This study primarily demonstrated the prevalence of falls, injuries and external causes of morbidity and mortality in the patients diagnosed with mental and behavioral disorders and/ or diseases of the nervous system which result greater than that of patients with other ICD-10 categories with statistical significance. The further analysis of associated factors from the completed study would contribute the prediction and the better management for patients with psychiatric and neurological disorder. **Correspond author: woraphat.rat@mahidol.ac. Abstract Background: First-degree relatives of patients with major psychiatric disease appear to be at higher risk of major psychiatric disease, but estimates for risks of different psychiatric disease in first-degree relatives are still lack or unreliable. Methods: Using the Taiwan National Health Insurance Research Database from 1996 to 2011, a population-based cross-sectional family study(N = 23258175) was conducted and of these 431887 subjects had psychiatric disease. Relative Ratios (RRs) with 95% CIs were calculated to identify the risk for major psychiatric disorders in first-degree relatives. We also estimate the gene(heritability), shared and non-shared environmental factors to psychiatric disease susceptibility. Result: Subjects with at least one first-degree relatives with psychiatry disease were more likely to have 2.48-fold prevalence of suffering psychiatric disease (prevalence, 5.4% v.s. 2.2%). The Relative risks(RRs) were 3.09 (3.04-3.15) for developing bipolar disease, 2.58 (2.56-2.61) for major depressive disorder(MDD), 2.27 (2.24-2.31) for schizophrenia and 2.24 (2.23-2.26) for depression. No obvious sexually dimorphic was found except higher schizophrenia risk in first-degree relative for female patients with psychiatric disease and higher depression risk for male patients with psychiatric disease. In addition, compared to other ages, for subjects having psychiatric disease diagnosed under twenty years old, higher RR in their first degree relatives were found that revealed 4.44 for psychiatric disease, 4.8 for bipolar disease, 4.4 for MDD, 4.3 for schizophrenia, and 3.8 for depression.
This first large-scale epidemiological study has provided the evidence of risk in genetic transferring among the first-degree relatives of patients with different major psychiatric disease, especially for bipolar disorder. More concerning should be considered when counseling families with affected patients, and should pay more attention to their first degree relative of subjects who have psychiatric diseases diagnosed under twenty years old. Abstract Objectives: Non-adherence to medication is a major problem in clinical medicine, and it is important to identify predictive factors. This study aims to investigate the prevalence and related factors to medication adherence in chronic psychiatric disorder. Methods: A total of 65(34 male and 31 female) outpatients with schizophrenia and bipolar disorder were randomly selected to participate in a survey. Medication adherence was assessed using Korean version of Drug Attitude Inventory-10(KDAI-10), Korean version of Medication Adherence Rating Scale(K-MARS), Korean version of Beck Cognitive Insight Scale(K-BCIS). Demographic and clinical variables, medication use information were also collected using self-reported questionnaires.
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For data analysis, we dichotomized the responses as "never missed taking medicine" versus all other responses, because our sample had a high overall adherence rate. Results: The prevalence of full medication adherence was 44.6%(29/65). Results of analysis showed that older age(r=.323, p=.009), longer duration of illness(r=.296, p=.017), doing work(F=4.407, p=.016), keeping marriage(F=5.256, p=.008), and living with family members(F=3.019, p=.025) were higher in KDAI-10 score. Also K-MARS was positively correlated age and duration of illness(respectively r=.398, p=.001; r=.407, p=.001). In ANOVA, keeping marriage and living with family member were significantly higher score in K-MARS than not married patients who live alone or with parents(respectively p=.006, p=.016). Finally, we found that medication adherence was not related to insight of their illness and education level. Conclusion: This study suggests that medication non-adherence is common amongst individual with chronic psychiatric disorder. Medication adherence of schizophrenia and bipolar disorder patients was more affected by social and familial support rather than insight or educational level. Given access to more information, and importantly to emotional support could be helped to make treatment choices that adequately reflect the long-term risk of non-adherence. Key words: Medication adherence, Schizophrenia, Bipolar disorder
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Impact of anxiety and depression on physical health condition and disability in an elderly Korean population Methods: In total, 1204 community-dwelling individuals aged 65 and older were evaluated at baseline, and of these 909 (75%) were re-assessed two years later. Anxiety and depression were identified at baseline using questions from the community version of the Geriatric Mental State diagnostic schedule (GMS-B3). Participants were assessed for functional disability and for 11 physical disorders both at baseline and at follow-up; disability was evaluated using the World Health Organization Disability Assessment Schedule II (WHODAS II). Baseline covariates of anxiety and depression included demographic status, years of education, rural/urban residence, accommodation, past and current occupation, monthly income, marital status, physical activity, and cognitive function. Results: Anxiety alone was associated with the incidence of heart disease, depression alone with the incidence of asthma, and comorbid anxiety and depression with incidence of eyesight problem, persistent cough, asthma, hypertension, heart disease, and gastrointestinal problems. Comorbid anxiety and depression were associated with an increase in the number of physical disorders and the degree of disability during the twoyear follow-up, compared to anxiety or depression alone or the absence of anxiety or depression. Conclusions: Anxiety, depression, and particularly their comorbidity should be assessed in the elderly population considering their longitudinal effects on physical disorders and disability. Future study is required to determine whether interventions aimed at these disorders can mitigate their impacts.
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Effect of group rehabilitation program on cardiopulmonary function, quality of life in breast cancer related lymphedema patients 
Methods:
The subjects of this study were patients who had diagnosed breast cancer stage 1-3 and had a lymphedema. A total of two patients (patient group) and four age matched healthy women (control group) were recruited. All of the subjects were measured cardiopulmonary exercise capacity, isokinetic muscle strength, quality of life (BDI, FACT-G, QLQ-C30, QLQ-BR23). All patients participated in 4 weeks rehabilitation program that consists of aerobic exercise using treadmill, ergometer and muscle strengthening exercise using theraband. They were measured exercise capacity, muscle strength, psychological aspects after rehabilitation program.
Results:
Before rehabilitation program, lymphedema group had significant lower exercise capacity in metabolic equivalent tasks(METs) [ 
